These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 869334)

  • 1. Carcinoembryonic antigen levels in pancreatic carcinoma.
    Paloyan D; Simonowitz D
    Am Surg; 1977 Jun; 43(6):410-2. PubMed ID: 869334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carcinoembryonic antigen assay in fine needle aspirate of pancreas: a diagnostic adjunct to cytology.
    Pinto MM; Levine RH
    Am J Gastroenterol; 1992 Apr; 87(4):530-3. PubMed ID: 1553944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential localization of human pancreas cancer-associated antigen and carcinoembryonic antigen in homologous pancreatic tumoral xenograft.
    Tan MH; Shimano T; Chu TM
    J Natl Cancer Inst; 1981 Sep; 67(3):563-9. PubMed ID: 6944528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prognostic value of the tumour markers CA 195 and CEA in patients with adenocarcinoma of the pancreas.
    Taylor OM; Cooper EH; Benson EA; McMahon MJ
    Eur J Surg Oncol; 1992 Oct; 18(5):508-13. PubMed ID: 1426303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pancreatic oncofetal antigen (POA) and carcinoma of the pancreas].
    Homma T; Oguchi H; Kawa S; Nagata A; Furuta S
    Gan No Rinsho; 1984 May; 30(6 Suppl):558-62. PubMed ID: 6205174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperative serum carcinoembryonic antigen and carbohydrate antigen 19-9 levels for the evaluation of curability and resectability in patients with pancreatic adenocarcinoma.
    Fujioka S; Misawa T; Okamoto T; Gocho T; Futagawa Y; Ishida Y; Yanaga K
    J Hepatobiliary Pancreat Surg; 2007; 14(6):539-44. PubMed ID: 18040617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum CA 242 in pancreatic cancer. Comparison with CA 19-9 and CEA.
    Pezzilli R; Billi P; Plate L; Laudadio MA; Sprovieri G
    Ital J Gastroenterol; 1995; 27(6):296-9. PubMed ID: 8562994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carcinoma of the pancreas. Detection and monitoring by carcinoembryonic antigen (CEA) and ultrasonography.
    Lokich JJ; Chawla PL; Smith EH
    Am J Gastroenterol; 1974 Dec; 62(6):481-7. PubMed ID: 4447096
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical use of carcinoembryonic antigen (CEA) determination].
    Mach J
    Bull Cancer; 1975; 62(4):445-52. PubMed ID: 1212528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mucinous cystic neoplasm of the pancreas with high carcinoembryonic antigen.
    Yu HC; Shetty J
    Arch Pathol Lab Med; 1985 Apr; 109(4):375-7. PubMed ID: 3885900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor markers in patients with pancreatic carcinoma.
    Gattani AM; Mandeli J; Bruckner HW
    Cancer; 1996 Jul; 78(1):57-62. PubMed ID: 8646727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Carcinoembryonic antigen (CEA), serum amylase and pancreozymin-secretin test in relation to stages of pancreatic cancer].
    Kozu T; Imaizumi T; Hanyu F; Takeuchi T; Nakamura K; Oi I; Toki F; Fukushima Y; Tomatsu S; Yoshikawa T
    Gan No Rinsho; 1983 Aug; 29(10):1104-10. PubMed ID: 6195362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The CEA test and other immunological tests as disease course controls in gastrointestinal adenocarcinoma].
    Hasler E; Spengler A; Berchtold R; Brunner KW; de Weck A
    Schweiz Med Wochenschr; 1977 Nov; 107(47):1683-91. PubMed ID: 929129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significance of carcinoembryonic antigen levels and cytology of pure pancreatic juice in diagnosis of pancreatic cancer.
    Tatsuta M; Yamamura H; Yamamoto R; Okano Y; Morii T; Okuda S; Tamura H
    Cancer; 1983 Nov; 52(10):1880-5. PubMed ID: 6627206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Localization and concentration of carcinoembryonic antigen (CEA) in gastrointestinal tumors: correlation with CEA levels in plasma.
    Wagener C; Müller-Wallraf R; Nisson S; Gröner J; Breuer H
    J Natl Cancer Inst; 1981 Sep; 67(3):539-47. PubMed ID: 6944526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carcinoembryonic antigen as a predictive factor for postoperative tumor relapse in early-stage lung adenocarcinoma.
    Sakao Y; Tomimitsu S; Takeda Y; Natsuaki M; Itoh T
    Eur J Cardiothorac Surg; 2004 Apr; 25(4):520-2. PubMed ID: 15037265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased levels of both carbohydrate antigen 19-9 and duke pancreatic monoclonal antigen type 2 reflect postoperative prognosis in patients with pancreatic carcinoma.
    Shibata K; Iwaki K; Kai S; Ohta M; Kitano S
    Pancreas; 2009 Aug; 38(6):619-24. PubMed ID: 19436235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic significance of cancer antigen 125, pancreatic oncofetal antigen, and carcinoembryonic antigen in malignant and tuberculous pleural effusions.
    Niwa Y; Shimokata K
    Jpn J Clin Oncol; 1986 Mar; 16(1):3-8. PubMed ID: 3009919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum carcinoembryonic antigen in the differential diagnosis of pancreatic cancer: influence of tumour spread, liver impairment, and age.
    Basso D; Fabris C; Del Favero G; Angonese C; Meggiato T; Infantino A; Plebani M; Piccoli A; Leandro G; Burlina A
    Dis Markers; 1988; 6(3):203-7. PubMed ID: 3168400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunological diagnosis of pancreatic cancer by assaying carcinoembryonic antigen (CEA) in pure pancreatic juice.
    Nishida K; Yoshikawa T; Kondo M; Thiele HG
    Hepatogastroenterology; 1980 Dec; 27(6):488-94. PubMed ID: 7203382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.